WC
WCH.XETRA Wacker Chemie AG
- Market cap
- EUR 3.95B
- P/E
- -
- P/B
- 1.09x
- ROE
- 17.7%
- Dividend yield
- 3.14%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is WCH.XETRA undervalued?
Graham numberThe Graham number of Wacker Chemie AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Wacker Chemie AG fundamental analysis
No fundamental analysis for Wacker Chemie AG yet.
Wacker Chemie AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Wacker Chemie AG
Wacker Chemie AG, together with its subsidiaries, produces and sells chemical products in Europe, Asia, the Americas, and internationally. The company operates through four segments: Silicones, Polymers, Biosolutions, and Polysilicon. It offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica; and binders and polymeric additives, including dispersible polymer powders and dispersions. The company also provides…
Full company profileWacker Chemie AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Wacker Chemie AG annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 4.63B | 4.92B | 4.98B | 4.93B | 4.69B | 6.21B | 8.21B | 6.40B | 5.72B | 5.49B | 5.85B |
| Gross Profit | 823M | 954M | 875M | 691M | 870M | 1.67B | 2.16B | 1.08B | 987M | 657M | 951M |
| Operating Income | 259M | 359M | 234M | 24.1M | 257M | 1.04B | 1.45B | 354M | 271M | -105M | 297M |
| EBITDA | 945M | 914M | 755M | -70.3M | 670M | 1.46B | 1.85B | 878M | 807M | 397M | 768M |
| Net Income | 179M | 232M | 246M | -643M | 189M | 807M | 1.25B | 314M | 241M | -821M | 712M |
| EPS | 3.61 | 4.67 | 4.95 | -13 | 3.81 | 16 | 25 | 6.31 | 4.85 | -17 | 14 |
| Balance Sheet | |||||||||||
| Total Assets | 7.46B | 6.84B | 7.12B | 6.49B | 6.95B | 8.13B | 9.40B | 8.85B | 9.41B | 8.79B | 8.72B |
| Total Liabilities | 4.87B | 3.67B | 3.97B | 4.46B | 5.26B | 5.03B | 4.37B | 4.27B | 4.57B | 5.04B | 4.54B |
| Shareholders' Equity | 2.38B | 3.12B | 3.09B | 1.97B | 1.63B | 3.02B | 4.86B | 4.42B | 4.67B | 3.60B | 4.02B |
| Cash & Short-term Investments | 460M | 553M | 384M | 547M | 1.34B | 1.67B | 1.78B | 1.39B | 1.22B | 1.48B | 1.57B |
| Total Debt | 1.03B | 663M | 701M | 954M | 1.23B | 1.25B | 1.34B | 1.51B | 1.95B | 2.37B | 2.30B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 737M | 657M | 510M | 605M | 874M | 1.06B | 1.13B | 936M | 310M | 550M | 385M |
| Capital Expenditure | 514M | 328M | 409M | 415M | 227M | 321M | 561M | 640M | 652M | 553M | 344M |
| Free Cash Flow | 222M | 329M | 101M | 190M | 647M | 743M | 564M | 297M | -341M | -2.80M | 41.2M |
| Ratios | |||||||||||
| ROE | 7.5% | 7.4% | 8.0% | -32.7% | 11.6% | 26.7% | 25.7% | 7.1% | 5.2% | -22.8% | 17.7% |
| ROA | 2.4% | 3.4% | 3.5% | -9.9% | 2.7% | 9.9% | 13.3% | 3.5% | 2.6% | -9.3% | 8.2% |
| Net Profit Margin | 3.9% | 4.7% | 4.9% | -13.0% | 4.0% | 13.0% | 15.2% | 4.9% | 4.2% | -15.0% | 12.2% |
| Debt to Equity | 0.43x | 0.21x | 0.23x | 0.49x | 0.76x | 0.41x | 0.28x | 0.34x | 0.42x | 0.66x | 0.57x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Wacker Chemie AG dividends
- Dividend yield
- 3.14%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- May 8, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 124M | 2.50 | - |
| 2024 | EUR 149M | 3.00 | 61.8% |
| 2023 | EUR 596M | 12 | 190.1% |
| 2022 | EUR 397M | 8.00 | 31.8% |
| 2021 | EUR 99.4M | 2.00 | 12.3% |
| 2020 | EUR 24.8M | 0.50 | 13.1% |
| 2019 | EUR 124M | 2.50 | - |
| 2018 | EUR 224M | 4.50 | 90.9% |
| 2017 | EUR 99.4M | 2.00 | 42.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Wacker Chemie AG
- Insiders 62.17%
- Institutions 11.64%
- Public & others 26.19%
- Shares outstanding 49.7M
- Free float 17.3M
Wacker Chemie AG company profile
- Company name
- Wacker Chemie AG
- Ticker
- WCH.XETRA
- ISIN
- DE000WCH8881
- Exchange
- XETRA Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 15,916
- Fiscal year end
- December
- Address
- Gisela-Stein-Strasse 1, Munich, Germany, 81671
- Phone
- 49 89 6279 0
- Website
- wacker.com
About Wacker Chemie AG
Wacker Chemie AG, together with its subsidiaries, produces and sells chemical products in Europe, Asia, the Americas, and internationally. The company operates through four segments: Silicones, Polymers, Biosolutions, and Polysilicon. It offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica; and binders and polymeric additives, including dispersible polymer powders and dispersions. The company also provides pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone, as well as pharmaceutical actives, food additives, and agrochemicals; and hyperpure polysilicon. In addition, it engages in forums; e-business, such as ERP system, EDI integration, delivery forecast, and e-invoicing; and support services. The company serves automotive, construction, chemical, semiconductor, consumer goods, medical technology, pharmaceutical, and photovoltaic industries. It exports its products. The company was formerly known as Wacker-Chemie GMBH and changed its name to Wacker Chemie AG in October 2005. Wacker Chemie AG was founded in 1914 and is headquartered in Munich, Germany. The company operates as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
Wacker Chemie AG management
10- Dr. Christian HartelCEO, President & Member of Executive Board · born 1971
- Dr. Tobias OhlerCFO & Member of the Executive Board · born 1971
- Ms. Angela WorlHead of Human Resource, Personnel Director & Member of Executive Board · born 1968
- Dr. Christian KirstenMember of the Executive Board
- Mr. Rainald HagenhuesHead of Corproate Accounting & Tax
- Mr. Joerg Hoffmann C.F.A.Head of Investor Relations
- Mr. Joerg KreySenior Vice President of Corporate Engineering & CDO Operations
- Mathias WiedemannPresident of Biosolutions division
- Ms. Martina Schulze-AdamsSenior VP of Corporate R&D and Head of Consortium
- Mr. Peter SummoPresident of Polymers Business